Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Executive Insights Life Sciences & Pharma Oncology BD&L: Winning in an Increasingly Competitive Environment September 12, 2024
Video / Webinar Healthcare Services AI in Healthcare: Passive, Reactive, or Proactive? August 2, 2024
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024
Podcast Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies July 10, 2024
Published Articles Marketing & Sales Understanding the ‘Cookie Apocalypse’ and Its Impact on Online Advertising February 23, 2024
